Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
115,941,624
-
Share change
-
+29,219,157
-
Total reported value
-
$1,620,592,334
-
Put/Call ratio
-
72%
-
Price per share
-
$13.98
-
Number of holders
-
148
-
Value change
-
+$436,517,339
-
Number of buys
-
87
-
Number of sells
-
54
Institutional Holders of IMMUNOMEDICS INC - COM (IMMU) as of Q3 2017
As of 30 Sep 2017,
IMMUNOMEDICS INC - COM (IMMU) was held by
148 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
115,941,624 shares.
The largest 10 holders included
venBio Select Advisor LLC, ORBIMED ADVISORS LLC, BlackRock Inc., ACUTA CAPITAL PARTNERS, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, VANGUARD GROUP INC, ArrowMark Colorado Holdings LLC, and Palo Alto Investors, LLC.
This page lists
148
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.